Bülow N

No ORCID on file · 1 paper in corpus

2026

Prevalence of an endogenous LH rise following final GnRH antagonist dose in the IVF antagonist protocol.

European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2026.100454

BackgroundThe GnRH antagonist protocol is widely used in IVF/ICSI treatments. It involves daily injections of a GnRH antagonist starting on stimulation day 5 or later to prevent premature ovulation by suppressing the endogenous gonadotropin…